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Abstract
Adeno-associated virus (AAV) serotypes 1 to 5 are currently under development as clinical gene delivery vectors for the treatment of
human diseases. However, the ubiquitous nature of their cell surface receptors, heparin sulfate (AAV2 and 3) and sialic acids (AAV4 and
5), can preclude specific tissue targeting in vivo. Structural studies of AAV4 were initiated to characterize its capsid surface for re-targeting
manipulations. Crystals obtained diffracted synchrotron radiation to 3.2 Å resolution. The unit cell is body-centered orthorhombic, I222,
with a  339.6, b  319.2 and c  285.0 Å. The virus particle orientation and position have been determined.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The five distinct serotypes of adeno-associated viruses
(AAV1 to AAV5), members of the Parvoviridae family, are
helper dependent parvoviruses (Muzyczka and Berta, 2001).
The past few years have seen rapid progress in the develop-
ment of the AAV serotypes for gene therapy applications.
They are non-pathogenic, non-toxic and can package and de-
livery foreign genes to target cells. However, it is becoming
evident that the different serotypes have unique cellular bind-
ing characteristics (Kaludov et al., 2001; Walters et al., 2002;
Rabinowitz et al., 2002) despite the fairly high sequence ho-
mology between their capsid sequences. AAV2 and AAV3
that are87% identical utilize heparin sulfate as their primary
receptor (Summerford and Samulski, 1998; Handa et al.,
2000), but with different binding affinities (Rabinowitz et al.,
2002). AAV1 that is 83% identical to AAV2 does not bind
heparin sulfate (Rabinowitz et al., 2002). AAV4 and AAV5
that are55% identical to AAV2 and to each other bind sialic
acid, not heparin sulfate (Davidson et al., 2000; Rabinowitz et
al., 2002). Recently it was shown that AAV4 binds 2,3
O-linked sialic acids, while AAV5 binds both 2-3 and 2-6
N-linked sialic acids (Kaludov et al., 2001; Walters et al.,
2002). These tropism differences and the desire to improve
AAV gene therapy applications have generated significant
interest in the capsid structure of the different serotypes (Xie et
al., 2002). This paper reports the production, purification and
preliminary X-ray crystallographic studies of AAV4. The de-
termination of the atomic structure of AAV4 is critical for fully
elucidating its functional domains as it relates to receptor
binding and antigenic properties. Understanding these archi-
tectural designs will maximize its exploitation for gene therapy
applications.
Results and discussion
Virus production, purification and crystallization
Wild-type AAV4 particles were produced in Cos cells
and purified using a CsCl density gradient and centri-prep
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filtration for structural studies by X-ray crystallography.
Approximately 1  105 DNase resistant particles/cell were
obtainable in each preparation. SDS–PAGE (Fig. 1A) and
negative stain electron microscopy (Fig. 1B) confirmed the
purity and quality of the virus particles, respectively. The
amount of sample obtained after purification was adequate
for crystallization experiments.
Small diamond-like crystals, approximately 0.2  0.2 
0.2 mm in size, were obtained in 4 to 8 weeks (Fig. 1C)
from purified AAV4 samples. Good quality crystals suitable
Fig. 1. AAV4 production, purification and X-ray diffraction data. A) SDS–PAGE of purified wild-type AAV4 particles. The number of purified DNAase
resistant genomes was calculated by QPCR. Lane A shows 5  1011 particles from the CsCl gradient fractions and Lane B shows 2  1011 particles from
the final purification step, resuspended in SDS sample buffer and separated on a 4–21% polyacrylamide gel. The gel was stained with SyproRed and
visualized using storm 860. The positions of molecular weight standards and the three AAV4 coat proteins are indicated. B) An electron micrograph of
purified AAV4 particles stained with 2% uranyl acetate and applied to a 400 mesh carbon coated cooper grid. The micrograph was taken with a Joel
JEM-100CX II electron microscope at a magnification of 40,000. The magnification bar represents 1000 Å. C) An optical photograph of the AAV4 crystals
in a hanging drop, taken with a Zeiss Axioplan 2 microscope. The approximate dimensions of the crystals are 0.2  0.2  0.2 mm. D) A magnified portion
of a typical 0.25° oscillation photograph for an AAV4 crystal diffracting X-rays to 3.2 Å resolution. The image was collected on an ADSC Quantum4 CCD
detector at the F1 beam line (  0.916 Å) at the Cornell High Energy Synchrotron Source with an exposure time of 90s and a crystal to detector distance
of 300 mm. The black curved line shows the demarcation of the 3.5 Å resolution diffraction shell.
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for X-ray diffraction data collection were obtained using
virus concentrations ranging from 2 to 4 mg/ml in 20 mM
Tris–HCl, pH 7.5, with 2 mM MgCl, 150 mM NaCl and
1–1.5% PEG8000.
Data collection and processing
Initial room temperature X-ray diffraction data collection
tests at the F1 station at CHESS showed the AAV4 crystals
to be ordered to at least 3.2Å resolution. However, the
crystals were highly sensitive to synchrotron radiation dam-
age, with only 2–4 images being collected per crystal. To
overcome this radiation sensitivity problem, a suitable cryo-
protectant solution was developed. This solution contained
the crystallization conditions, with the percentage of the
PEG increased to 5%, plus 30% glycerol. During the data
collection the frozen crystals still showed the effects of
radiation damage (slow decay of X-ray diffraction pattern
resolution and increased mosaicity) with prolonged expo-
sure to X rays, although this was drastically reduced com-
pared to room temperature data collection. A total of 276
images were collected from 6 frozen crystals (average of
45 images each) that all diffracted X rays to at least 3.5Å
resolution; 4 of the crystals diffracted X rays to 3.2Å reso-
lution (Fig. 1D).
The intensity data were initially processed (Otwinowski
& Minor, 1997) to 3.5Å resolution with the orthorhombic
crystal system I222 with unit cell parameters a  339.6, b
 319.2, and c  285.0 Å. The data set was merged to
163,565 independent reflections (84.3% complete overall
and 83.2% complete in the outermost resolution shell),
resulting in an Rsym of 15.9% (26.9% in the outermost
resolution shell). The resolution of the processing was then
extended to 3.2 Å to include the few higher resolution
reflections, resulting in an Rsym of 16.4% (42.6% in the
outermost resolution shell) for 192,100 merged independent
reflections (75.9% complete overall, 42.6% complete in the
outermost resolution shell) (Table 1). The quality and per-
centage of data (Table 1) is comparable or better than those
that have been used for the structure determination of other
parvovirus capsids (e.g., Agbandje et al., 1993; Llamas-Saiz
et al., 1997; Simpson et al., 2002), including AAV2 (Xie et
al., 2002). The average reflection intensity (I) to noise (I)
ratio, [I/(I)], was 4.41 for data up to 3.2 Å resolution
(Table 2).
The orthorhombic cell dimensions and the molecular
weight of the AAV4 virus give a VM (Matthews, 1968)
value of 4.3, 2.2 and 1.1 Å3/Da for one, two, and four
particle per unit cell, respectively. By comparison of VM
values for other virus crystals, the only reasonable value is
two particles per unit cell with a solvent content of 41%,
assuming a molecular density of 1.30 g/cm3 (Table 2).
There are two possible body-centered orthorhombic
space groups I222 and I212121 (Henry and Lonsdale, 1969).
On consideration of packing constraints for two particles in
these space groups the most likely space group was I222,
with both particles having the same orientation, with 3
mutually perpendicular twofold icosahedral symmetry axes
coincident with the crystallographic twofold axes. Table 2
gives a summary of the data collection and crystal charac-
terization results.
Determination of particle orientation and position
The orientations of the two AAV4 particles in the unit
cell were determined with self-rotation functions (Ross-
mann and Blow, 1962). The function was explored search-
ing for 5-, 3- and 2-fold icosahedral symmetry axes of the
virus particles. The rotation function for   72° (to search
for the fivefold non-crystallographic symmetry axes direc-
tions) is shown in Fig. 2a. The observed peaks were con-
sistent with an orientated standard icosahedron, having
three mutually perpendicular twofold axes parallel to the a,
b and c unit cell axes (Fig. 2b). The rotation functions for
Table 1
Crystal data set statistics
Resolution shells (Å) No. of unique
reflections
Completeness (%) Rsym*
50.00 7.53 15111 75.8 0.085
7.53 5.98 16556 84.8 0.114
5.98 5.23 16594 85.5 0.132
5.23 4.75 16548 85.4 0.142
4.75 4.41 16565 85.8 0.156
4.41 4.15 16575 85.8 0.174
4.15 3.94 16559 85.8 0.200
3.94 3.77 16565 86.0 0.224
3.77 3.63 16477 85.6 0.252
3.63 3.50 16015 83.2 0.269
Total to 3.50 163565 84.3 0.159
3.5 3.31 18732 50.8 0.379
3.31 3.20 10703 42.6 0.426
Total to 3.20 186958 75.9 0.164
* Rsym is defined as (II/I, where I is the intensity of an
individual reflection and I is the average intensity for this reflection;
the summation is over all intensities.
Table 2
Summary of data collection parameters and crystal characterization#
Crystal dimensions (mm) 0.2  0.2  0.2
Temperature (K) 100
Wavelength (Å) 0.916
Resolution range (Å) 50-3.5 (3.2)
Crystal System Orthorhombic
Space group 1222
Unit cell parameters (Å) a  339.6 b  319.2 c  285.0
Total number of reflections 3109095 (3500729)
No. of Unique reflections 163565 (192100)
Rsym* 15.9 (16.4)
Completeness (%) 84.3 (75.9)
Average I/(I) 4.41
No. of particles 2
Solvent content (%) 41
VM (Å3/Da) 2.2
# Data statistics at 3.2Å resolution are given in the parenthesis.
* Rsym definition is as in Table 1.
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kappa 120° and 180° were calculated and were consistent
with this orientation (data not shown). The rotation function
searches showed that the two virus particles in the unit cell
have the same orientation (only one unique orientation was
observed) and that the virus particles share twofold symme-
try axes with the I222 space group.
Packing of the AAV4 particles in the I222 unit cell, with
their crystallographically constrained orientations, requires




2). This would allow
the particles to have a maximum diameter of 285 Å. This
is consistent with the diameter of parvovirus particles that
are approximately 260 Å (Agbandje et al., 1995).
Initial phases for the AAV4 X-ray diffraction data has
been calculated to 3.2 Å resolution using the CNS program
(Bru¨nger et al., 1998) from a poly-alanine feline panleuko-
penia virus (FPV) model (Agbandje et al., 1993) directly
oriented and positioned in the I222 unit cell. This model
resulted in an initial phasing Rfactor of 47%, (Rfactor 
(Fobs|  |Fcalc/|Fobs|), where Fobs and Fcalc represent the
observed data and calculated (from the model) amplitudes,
respectively). Thus, a molecular replacement model is at
hand. Using 15-fold non-crystallographic symmetry to av-
erage the calculated electron density maps, the structure
determination of AAV4 to 3.2 Å resolution should proceed
without difficulties. This preliminary work represents a ma-
jor step toward obtaining the essential high resolution struc-
tural data for AAV4 required for understanding the proper-




Cos cells used for viral production were maintained as
monolayer cultures in D10 medium (Dulbecco’s modified
Eagle’s medium containing 10% fetal calf serum, 100 U of
penicillin per ml, 100 mg of streptomycin per ml, and 13 U
amphotericin B as recommended by the manufacturer
(GIBCO, Gaithersburg, MD). Wild-type AAV4 was pro-
duced in the Cos cells by infection with AAV4 (m.o.i. 100)
and adenovirus type 5 (m.o.i. 10). The infected cells were
harvested by scraping at 48 h post infection and virus was
then purified and concentrated as described by Kaludov et
al., 2001, with the following modifications. The virus was
initially purified with a 1.4 g/cm3 CsCl density gradient by
centrifugation at 38 K for 65 h at 4°C. The semi-purified
virus was concentrated on centri-prep 100 filters (Millipore)
and washed with a 1% deoxycolic acid solution to remove
contaminating proteins co-purified in the CsCl gradient. The
virus was then washed with 20 mM Tris–HCl, pH 7.5, with
2 mM MgCl and 150 mM NaCl and re-concentrated to
approximately 3 to 4  1014 particles/ml (3–4 mg/ml)
using the centri-prep 100 filters. Viral titer was determined
by QPCR as described by Kaludov et al., 2001. One micro-
liter of purified virus was added to a PCR reaction contain-
ing 1X SYBR Green master mix (ABI, Foster City, CA),
0.25 pmol/l forward and reverse primers and amplification
was detected using an ABI 7700 sequence detector (ABI,
Foster City, CA). Specific primers for AAV4 were designed
by using the primer express program (ABI, Foster city, CA):
Forward 5	-ACCAACATCGCGGAGGC, Reverse 5	-
Fig. 2. Stereographic projections showing rotation function results for the
AAV4 X-ray diffraction data. A) The rotation function for   72°,
showing a search for fivefold icosahedral symmetry elements, using the
observed data set in the 10 to 3.5 Å resolution range, with a radius of
integration of 120 Å. The map is contoured at 3. B) The definition of a
standard icosahedral orientation, back solid pentagons, triangles and ellip-
soids represent 5-, 3- and 2-fold symmetry axes, respectively. Three mu-
tually perpendicular icosahedral twofold axes are parallel to the unit cell a,
b and c axes.
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CCCTCCTCCCACCAGATCA. Following a 96°C 10 min
denaturing step, cycling conditions were 96°C for 15 s,
60°C for 1 min for 40 cycles. The viral DNA in each sample
was quantified by comparing the fluorescence profiles with
a set of DNA standards.
Negative stain electron microscopy
Purified AAV4 particles were viewed using a Joel JEM-
100CX II electron microscope (EM) at a magnification of
40 K. Five microliters of purified virus, at an estimated
concentration of 0.3 mg/ml, was spotted onto a 400 mesh
carbon coated copper grid (Ted Pella, Inc., Redding, CA)
for 1 min before blotting with filter paper (Whatman # 5).
The sample was then negatively stained with 5 l of 2%
uranyl acetate for 10 s, blotted dry and viewed with the EM.
Crystallization
Crystallization conditions were initially screened, based
on previously reported conditions used for autonomous par-
voviruses (Tsao et al., 1992; Agbandje et al., 1993; Llamas-
Saiz et al., 1997), using hanging drop vapor diffusion
(McPherson, 1982) in VDX 24 well plates and siliconized
cover slips (Hampton Research, Laguna Niguel, CA). The
conditions were further refined by searching virus concen-
tration (2–4 mg/ml) and percentages (0.5–3%) of polyeth-
ylene glycol 8000 (PEG 8000). Crystallization drops con-
tained 2 l of virus mixed with 2 l of precipitant solution
consisting of 20 mM Tris–HCl, pH 7.5, with 2 mM MgCl,
150 mM NaCl and PEG8000. The drops were equilibrated
by vapor diffusion against 1ml of precipitant solution at
room temperature.
X-ray diffraction data collection and processing
All X-ray diffraction data were collected at the F1 beam
line at the Cornell High energy Synchrotron Source
(CHESS, Ithaca, NY), using an ADSC Quantum4 CCD
detector system. The X-ray diffraction data collection was
performed at cryo (100 K) temperatures after initially
testing the diffraction quality at room temperature. The
crystals were transferred to a freshly prepared cryo pro-
tectant solution consisting of 30% glycerol in the precipitant
solution (20 mM Tris–HCl, pH 7.5, with 2 mM MgCl, 150
mM NaCl and PEG8000). The crystals were allowed to
equilibrate for 5 min and then mounted on a thin fiber (0.2
mm) cryo-loop (Hampton Research) and transferred into a
cryo stream (Oxford Cryosystems, Oxford, UK) for flash
freezing. Data were collected at a wavelength of   0.916
Å with a 0.2 mm collimator and a crystal-to-detector dis-
tance of 300 mm. All images were collected using a 0.25°
oscillation angle with exposure times ranging from 60 to
120 s per image.
The collected diffraction data were indexed using the
software DENZO and scaled and reduced with SCALE-
PACK (Otwinowski and Minor, 1997).
Determination of particle orientation and position
The orientations of the virus particles in the crystal unit
cell were determined with a self-rotation function (Ross-
mann and Blow, 1962) using the GLRF program (Tong and
Rossmann, 1990). The self-rotation function calculation
was computed using10% of the observed data between 10
to 3.5 Å resolution at kappa angles of 72° (fivefold), 120°
(threefold) and 180° (twofold) with the radius of integration
set to 120 Å. The particle position was inferred by packing
considerations. The previously determined structure of FPV
(Agbandje et al., 1993) was used as an initial phasing
model. All the side chains were removed and fifteen copies
of a poly-alanine capsid protein model were directly orien-
tated and positioned in the I222 unit cell. The crystallo-
graphic symmetry operators were applied to generate the
two complete icosahedral particles in the unit cell. The
initial phases were then calculated from the model to 3.2 Å
resolution using the CNS program (Bru˜nger et al., 1998).
All calculations were performed on an RS10000 computer
(Silicon Graphics Inc., Orlando, FL).
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